Table 3.
Mfx | AOT | OCA | ACI | |
---|---|---|---|---|
Partial weightbearing | 47 studies | 32 studies | 51 studies | 42 studies |
First week | 26 (55.3%) | 6 (18.8%) | 7 (13.7%) | 17 (40.5%) |
1 week | — | 3 (9.4%) | 3 (5.9%) | — |
2 weeks | 4 (8.5%) | 6 (18.8%) | 12 (23.5%) | 4 (9.5%) |
3 weeks | — | — | — | — |
4 weeks | 12 (25.5%) | 3 (9.4%) | 5 (9.8%) | 8 (19.0%) |
5 weeks | — | 1 (3.1%) | 1 (2.0%) | — |
6 weeks | 5 (10.6%) | 12 (37.5%) | 16 (31.4%) | 13 (31.0%) |
8 weeks | — | 1 (3.1%) | 6 (11.8%) | — |
12 weeks | — | — | 1 (2.0%) | — |
Full weightbearing | 43 studies | 30 studies | 44 studies | 40 studies |
First week | — | — | 2 (4.5%) | 4 (10%) |
1 week | — | 3 (10.0%) | 3 (6.8%) | — |
2 weeks | 1 (2.3%) | 5 (16.7%) | 10 (22.7%) | — |
4 weeks | 2 (4.7%) | 3 (10.0%) | 2 (4.5%) | — |
6 weeks | 23 (53.5%) | 13 (43.3%) | 14 (31.8%) | 10 (25%) |
7 weeks | 2 (4.7%) | 1 (3.3%) | — | 1 (2.5%) |
8 weeks | 15 (34.9%) | 4 (13.3%) | 6 (13.6%) | 8 (20%) |
9 weeks | — | — | — | 1 (2.5%) |
10 weeks | — | 1 (3.3%) | 1 (2.3%) | 10 (25%) |
12 weeks | — | — | 6 (13.6%) | 5 (12.5%) |
16 weeks | — | — | — | 1 (2.5%) |
18 weeks | — | — | 1 (2.3%) | — |
Time between partial and full weightbearing | 43 studies | 30 studies | 44 studies | 33 studies |
0 week | 2 (4.7%) | 17 (56.7%) | 25 (56.8%) | 4 (12.1%) |
2 weeks | 5 (11.6%) | 3 (10%) | 5 (11.4%) | 3 (9.1%) |
3 weeks | — | 2 (6.7%) | 1 (2.3%) | — |
4 weeks | 12 (27.9%) | 3 (10%) | 5 (11.4%) | 8 (24.2%) |
5 weeks | — | — | — | 1 (3.0%) |
6 weeks | 14 (32.6%) | 3 (10%) | 5 (11.4%) | 13 (39.4%) |
7 weeks | 2 (4.7%) | — | — | — |
8 weeks | 8 (18.6%) | 1 (3.3%) | 1 (2.3%) | — |
10 weeks | — | — | — | 4 (12.1%) |
12 weeks | — | — | 2 (4.5%) | — |
Mfx = microfracture; AOT = osteochondral autograft; OCA = osteochondral allograft; ACI = autologous chondrocyte implantation.